Preclinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH–Wild-type Glioblastoma

Rachael A. Vaubel, Wenjuan Zhang, Ju-Hee Oh, Ann C. Mladek, Tugce I. Pasa, Jennifer K. Gantchev, Katie L. Waller, Gerard Baquer, Sylwia A. Stopka, Michael S. Regan, Md Amin Hossain, Paul A. Decker, Matthew L. Kosel, Shiv K. Gupta, Sonia Jain, Paige P. Sarkaria, Zeng Hu, Lauren L. Ott, Brett L. Carlson, Katie K. Bakken, Surabhi Talele, Wenqiu Zhang, Keith L. Ligon, Eudocia Q. Lee, Jeanette E. Eckel Passow, Danielle M. Burgenske, Nathalie Y.R. Agar, William F. Elmquist, Jann N. Sarkaria

Open source

DOI: 10.1158/1078-0432.ccr-25-0244
Published: 2025-07-01
Container: Clinical Cancer Research
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-25-0244,
  title = {Preclinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH–Wild-type Glioblastoma},
  author = {Rachael A. Vaubel and Wenjuan Zhang and Ju-Hee Oh and Ann C. Mladek and Tugce I. Pasa and Jennifer K. Gantchev and Katie L. Waller and Gerard Baquer and Sylwia A. Stopka and Michael S. Regan and Md Amin Hossain and Paul A. Decker and Matthew L. Kosel and Shiv K. Gupta and Sonia Jain and Paige P. Sarkaria and Zeng Hu and Lauren L. Ott and Brett L. Carlson and Katie K. Bakken and Surabhi Talele and Wenqiu Zhang and Keith L. Ligon and Eudocia Q. Lee and Jeanette E. Eckel Passow and Danielle M. Burgenske and Nathalie Y.R. Agar and William F. Elmquist and Jann N. Sarkaria},
  year = {2025},
  journal = {Clinical Cancer Research},
  doi = {10.1158/1078-0432.ccr-25-0244},
  url = {https://doi.org/10.1158/1078-0432.ccr-25-0244}
}

RIS

TY  - JOUR
TI  - Preclinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH–Wild-type Glioblastoma
AU  - Rachael A. Vaubel
AU  - Wenjuan Zhang
AU  - Ju-Hee Oh
AU  - Ann C. Mladek
AU  - Tugce I. Pasa
AU  - Jennifer K. Gantchev
AU  - Katie L. Waller
AU  - Gerard Baquer
AU  - Sylwia A. Stopka
AU  - Michael S. Regan
AU  - Md Amin Hossain
AU  - Paul A. Decker
AU  - Matthew L. Kosel
AU  - Shiv K. Gupta
AU  - Sonia Jain
AU  - Paige P. Sarkaria
AU  - Zeng Hu
AU  - Lauren L. Ott
AU  - Brett L. Carlson
AU  - Katie K. Bakken
AU  - Surabhi Talele
AU  - Wenqiu Zhang
AU  - Keith L. Ligon
AU  - Eudocia Q. Lee
AU  - Jeanette E. Eckel Passow
AU  - Danielle M. Burgenske
AU  - Nathalie Y.R. Agar
AU  - William F. Elmquist
AU  - Jann N. Sarkaria
PY  - 2025
JO  - Clinical Cancer Research
DO  - 10.1158/1078-0432.ccr-25-0244
UR  - https://doi.org/10.1158/1078-0432.ccr-25-0244
ER  -

APA

Vaubel, R. A., Zhang, W., Oh, J., Mladek, A. C., Pasa, T. I., Gantchev, J. K., Waller, K. L., Baquer, G., Stopka, S. A., Regan, M. S., Hossain, M. A., Decker, P. A., Kosel, M. L., Gupta, S. K., Jain, S., Sarkaria, P. P., Hu, Z., Ott, L. L., Carlson, B. L., Bakken, K. K., Talele, S., Zhang, W., Ligon, K. L., Lee, E. Q., Passow, J. E. E., Burgenske, D. M., Agar, N. Y., Elmquist, W. F., & Sarkaria, J. N. (2025). Preclinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH–Wild-type Glioblastoma. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-25-0244

Source records

crossref · retrieved 2026-09-27T01:37:11.976Z